Use of degludec insulin in chronic complex patients

Published: 22 March 2018
Author(s): J. Carretero Gómez, J.P. Miramontes González, J.M. Varela Aguilar, J. Ena, J.C. Arévalo Lorido, Diabetes and Obesity Working Group of Spanish Society of Internal Medicine
Issue: March 2018
Section: Letter to the Editor

Diabetes mellitus has emerged as an important global public concern, affecting 422 million adults. In addition, it is expected that diabetes will become the 7th leading cause of death by 2030 [1]. Another important fact is that its prevalence increases rapidly with aging. As population ages and the rates of overweight or obese individuals continue to rise, both the prevalence and burden of diabetes in the elderly is expected to increase substantially over the next several decades. The prevalence of diabetes in the elderly is high; current estimates indicate that in the US, 26.9% of people ≥65 years of age are diagnosed with the condition [2].